TUBERCULOSIS MULTI DRUG RESISTANT ACTIVE

Clinical trials for TUBERCULOSIS MULTI DRUG RESISTANT ACTIVE explained in plain language.

Never miss a new study

Get alerted when new TUBERCULOSIS MULTI DRUG RESISTANT ACTIVE trials appear

Sign up with your email to follow new studies for TUBERCULOSIS MULTI DRUG RESISTANT ACTIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1

New 6-Month TB drug combo could replace Year-Long ordeal

Disease control Not yet recruiting

This study tests a new 6-month treatment called BPaLM for people with multidrug-resistant tuberculosis (MDR-TB) in France. It aims to see if this shorter regimen works as well as the standard long treatment that can last over a year. About 55 adults with confirmed MDR-TB will rec…

Matched conditions: TUBERCULOSIS MULTI DRUG RESISTANT ACTIVE

Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control

Last updated Apr 30, 2026 15:48 UTC

TUBERCULOSIS MULTI DRUG RESISTANT ACTIVE

Get alerted when new TUBERCULOSIS MULTI DRUG RESISTANT ACTIVE trials appear

New 6-Month TB drug combo could replace Year-Long ordeal